[go: up one dir, main page]

GB201116523D0 - Wound prognosis - Google Patents

Wound prognosis

Info

Publication number
GB201116523D0
GB201116523D0 GBGB1116523.0A GB201116523A GB201116523D0 GB 201116523 D0 GB201116523 D0 GB 201116523D0 GB 201116523 A GB201116523 A GB 201116523A GB 201116523 D0 GB201116523 D0 GB 201116523D0
Authority
GB
United Kingdom
Prior art keywords
prognosis
wound
wound prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1116523.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Systagenix Wound Management IP Co BV
Original Assignee
Systagenix Wound Management IP Co BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Systagenix Wound Management IP Co BV filed Critical Systagenix Wound Management IP Co BV
Priority to GBGB1116523.0A priority Critical patent/GB201116523D0/en
Priority to GB1118119.5A priority patent/GB2494934A/en
Publication of GB201116523D0 publication Critical patent/GB201116523D0/en
Priority to EP14188512.9A priority patent/EP2896963B1/en
Priority to CA2825863A priority patent/CA2825863A1/en
Priority to US13/982,913 priority patent/US9932622B2/en
Priority to PCT/GB2012/050199 priority patent/WO2012104620A2/en
Priority to BR112013019563A priority patent/BR112013019563A2/en
Priority to EP12701548.5A priority patent/EP2671081A2/en
Priority to EP12762381.7A priority patent/EP2745116A2/en
Priority to PCT/GB2012/052345 priority patent/WO2013041879A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/966—Elastase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1116523.0A 2011-01-31 2011-09-23 Wound prognosis Ceased GB201116523D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1116523.0A GB201116523D0 (en) 2011-09-23 2011-09-23 Wound prognosis
GB1118119.5A GB2494934A (en) 2011-09-23 2011-10-20 Wound prognosis
EP12701548.5A EP2671081A2 (en) 2011-01-31 2012-01-31 Wound prognosis
US13/982,913 US9932622B2 (en) 2011-01-31 2012-01-31 Wound prognosis
CA2825863A CA2825863A1 (en) 2011-01-31 2012-01-31 Wound prognosis
EP14188512.9A EP2896963B1 (en) 2011-01-31 2012-01-31 Wound prognosis
PCT/GB2012/050199 WO2012104620A2 (en) 2011-01-31 2012-01-31 Wound prognosis
BR112013019563A BR112013019563A2 (en) 2011-01-31 2012-01-31 methods for wound prognosis, for wound treatment, for predicting whether a patient may be responsive to treatment of a wound that exudes a wound fluid, and for treating a wound that exudes a wound fluid, a device for simultaneously or sequentially measuring the wound. hne and at least 1 mmp levels in a wound fluid sample, diagnostic apparatus, and kit.
EP12762381.7A EP2745116A2 (en) 2011-09-23 2012-09-21 Wound prognosis
PCT/GB2012/052345 WO2013041879A2 (en) 2011-09-23 2012-09-21 Wound prognosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1116523.0A GB201116523D0 (en) 2011-09-23 2011-09-23 Wound prognosis

Publications (1)

Publication Number Publication Date
GB201116523D0 true GB201116523D0 (en) 2011-11-09

Family

ID=44993342

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1116523.0A Ceased GB201116523D0 (en) 2011-01-31 2011-09-23 Wound prognosis
GB1118119.5A Withdrawn GB2494934A (en) 2011-01-31 2011-10-20 Wound prognosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1118119.5A Withdrawn GB2494934A (en) 2011-01-31 2011-10-20 Wound prognosis

Country Status (3)

Country Link
EP (1) EP2745116A2 (en)
GB (2) GB201116523D0 (en)
WO (1) WO2013041879A2 (en)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031223A1 (en) 1994-05-13 1995-11-23 Kuraray Co., Ltd. Medical polymer gel
GB2314842B (en) 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
GB2381452B (en) * 2001-11-05 2005-08-10 Johnson & Johnson Medical Ltd Wound monitoring
NZ533252A (en) * 2001-11-29 2006-03-31 Greystone Medical Group Inc Treatment of wounds and compositions employed
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
EP1576181B1 (en) 2002-01-31 2013-08-14 Systagenix Wound Management IP Co. BV. Method for detecting pathogenic bacteria in wounds
US8461410B2 (en) 2002-09-11 2013-06-11 Ethicon, Inc. Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8039228B2 (en) 2003-09-02 2011-10-18 Expressive Constructs, Inc. Signal amplification using a synthetic zymogen
GB2422664A (en) 2005-01-28 2006-08-02 Ethicon Inc Device for detecting an enzyme in a sample
GB2418145A (en) * 2004-09-17 2006-03-22 Ethicon Inc Wound treatment system
US20070142762A1 (en) * 2005-12-16 2007-06-21 Eastman Kodak Company Wound dressing
GB2437311A (en) 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
AU2007329228A1 (en) * 2006-12-07 2008-06-12 University Of Florida Research Foundation Inc. Materials and methods for efficient and accurate detection of analytes
GB2452076A (en) 2007-08-23 2009-02-25 Mologic Ltd Detection of enzymes by detecting binding of substrate recognition molecules to modified substrates
GB2454672A (en) 2007-11-13 2009-05-20 Mologic Ltd Chromogenic protease substrates
WO2010022281A1 (en) * 2008-08-20 2010-02-25 Greystone Pharmaceuticals, Inc. Methods for using human neutrophil elastase as an indicator of active wound infection
CA2764775C (en) * 2009-06-26 2019-02-26 University Of Florida Research Foundation, Inc. Rapid bed-side measurement of neutrophil elastase activity in biological fluids
WO2012104620A2 (en) * 2011-01-31 2012-08-09 Systagenix Wound Management Ip Co. B.V. Wound prognosis
GB2487729A (en) * 2011-01-31 2012-08-08 Systagenix Wound Man Ip Co Bv Measurement of matrix metalloproteinase (MMP) and elastase in wound fluid

Also Published As

Publication number Publication date
GB201118119D0 (en) 2011-11-30
WO2013041879A2 (en) 2013-03-28
WO2013041879A3 (en) 2013-05-30
GB2494934A (en) 2013-03-27
EP2745116A2 (en) 2014-06-25

Similar Documents

Publication Publication Date Title
GB2489947B (en) Wound dressing
PL2658024T3 (en) Tape
GB201602417D0 (en) Tape appliactor
PL3034071T3 (en) New combination
GB201301300D0 (en) No details
GB201104556D0 (en) Biomarkers
SI2565144T1 (en) Winch
EP2716258A4 (en) Intrastomal segment
GB201113968D0 (en) Prognostic methadology
GB201101663D0 (en) Wound prognosis
SI2592038T1 (en) Winch
GB2496444B (en) Winch
GB201101727D0 (en) Obuoy
GB201118119D0 (en) Wound prognosis
GB2496446B (en) Winch
AU5031P (en) BESYS Beschorneria yuccoides
GB201119196D0 (en) Biomarkers
GB201121280D0 (en) Biomarker
GB201107838D0 (en) Biomarker
ZA201403872B (en) New combination
GB201100775D0 (en) String winder
GB201104426D0 (en) PhilharmonicLights_b
GB201109046D0 (en) Future
GB201303586D0 (en) No details
GB201115167D0 (en) No details

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)